home / stock / gsk / gsk articles


GSK Articles, GlaxoSmithKline PLC - From 03/18/24

Stock Information

Company Name: GlaxoSmithKline PLC
Stock Symbol: GSK
Market: NYSE
Website: gsk.com

Menu

GSK GSK Quote GSK Short GSK News GSK Articles GSK Message Board
Get GSK Alerts

News, Short Squeeze, Breakout and More Instantly...

GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer | Benzinga

Saturday, GSK plc (NYSE:GSK) announced overall survival (OS) results from Part 1 and progression-free survival (PFS) results fr...

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B | Benzinga

Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)&nbs...

Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research | Benzinga

New York, United States, March 12, 2024 (GLOBE NEWSWIRE) -- Contraception encompasses the use of drugs to prevent pregnancy, the transmission of...

GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study | Benzinga

GSK plc (NYSE:GSK) released headline results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating Blenre...

Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows | Benzinga

ViiV Healthcare, majority owned by GSK Plc (NYSE:GSK), with Pfizer Inc (NYSE:PFE) and Shionogi Limited as shareholder...

Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO Report Says | Benzinga

The World Health Organization (WHO) released its latest HIV Drug Resistance (HIVDR) Report, shedding light on the growing areas of drug r...

Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges | Benzinga

The Biden administration is working to preserve a crucial federal mandate compelling health insurers to cover preventive care services, including ...

Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars | Benzinga

Haleon Plc’s (NYSE:HLN) fiscal year 2023 revenues increased 4.1% Y/Y to £11.3 billion, equivalent to around $14.03 billion, m...

GSK Settles Another California Lawsuit On Heartburn Drug Zantac Causing Cancer, Second Within A Month | Benzinga

Thursday, GSK Plc (NYSE:GSK) agreed to confidentially settle another lawsuit in California that had alleged its heartburn drug ...

GSK's Gepotidacin Oral Antibiotic Non-Inferior To Commonly Used Muscle-Injected Antibiotic Combo For Sexually Transmitted Infection | Benzinga

Monday, GSK plc (NYSE:GSK) released headline results from the pivotal EAGLE-1 phase 3 trial for gepotidacin, an oral antibiotic...

Previous 10 Next 10